|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 February 2002, Vol. 99, No. 4, pp. 1299-1304
NEOPLASIA
Analysis of the IgVH somatic mutations in
splenic marginal zone lymphoma defines a group of unmutated cases
with frequent 7q deletion and adverse clinical
course
Patricia Algara,
Marisol S. Mateo,
Margarita Sanchez-Beato,
Manuela Mollejo,
Immaculada C. Navas,
Lourdes Romero,
Francesc Solé,
Marta Salido,
Lourdes Florensa,
Pedro Martínez,
Elias Campo, and
Miguel A. Piris
From the Department of Genetics and Pathology, Virgen
de la Salud Hospital, Toledo, Spain; the Centro Nacional de
Investigaciones Oncologicas (CN10), Programa de Patologia Molecular,
Madrid, Spain, the Laboratory of Citología Hematológica,
Department of Pathology, Hospital del Mar, Barcelona, Spain; and the
Department of Pathology, Hospital Clinic, Barcelona, Spain.
This study aimed to correlate the frequency of somatic mutations in
the IgVH gene and the use of specific segments
in the VH repertoire with the clinical and
characteristic features of a series of 35 cases of splenic marginal
zone lymphoma (SMZL). The cases were studied by seminested polymerase
chain reaction by using primers from the FR1 and JH region.
The results showed unexpected molecular heterogeneity in this entity,
with 49% unmutated cases (less than 2% somatic mutations). The 7q31
deletions and a shorter overall survival were more frequent in this
group. Additionally a high percentage (18 of 40 sequences) of SMZL
cases showed usage of the VH1-2 segment, thereby
emphasizing the singularity of this neoplasia, suggesting that this
tumor derives from a highly selected B-cell population and encouraging
the search for specific antigens that are pathogenically relevant in
the genesis or progression of this tumor.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. KALPADAKIS, G. A. PANGALIS, E. DIMITRIADOU, M. K. ANGELOPOULOU, M. P. SIAKANTARIS, M.-C. KYRTSONIS, M. XIMERIS, T. TZENOU, S. SAHANAS, X. YIAKOUMIS, et al.
Mutation Analysis of IgVH Genes in Splenic Marginal Zone Lymphomas: Correlation with Clinical Characteristics and Outcome
Anticancer Res,
May 1, 2009;
29(5):
1811 - 1816.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Abramson, M. Chatterji, and A. Rahemtullah
Case 39-2008 -- A 51-Year-Old Woman with Splenomegaly and Anemia
N. Engl. J. Med.,
December 18, 2008;
359(25):
2707 - 2718.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Tracey, M. Aggarwal, M. Garcia-Cosio, R. Villuendas, P. Algara, M. Sanchez-Beato, A. Sanchez-Aguilera, J. F. Garcia, A. Rodriguez, F. I. Camacho, et al.
Somatic hypermutation signature in B-cell low-grade lymphomas
Haematologica,
August 1, 2008;
93(8):
1186 - 1194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Traverse-Glehen, L. Baseggio, E. C. Bauchu, D. Morel, S. Gazzo, M. Ffrench, A. Verney, D. Rolland, C. Thieblemont, J.-P. Magaud, et al.
Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?
Blood,
February 15, 2008;
111(4):
2253 - 2260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Kahl and D. Yang
Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL
Hematology,
January 1, 2008;
2008(1):
359 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Martin-Jimenez, R. Garcia-Sanz, A. Balanzategui, M. Alcoceba, E. Ocio, M{a} L. Sanchez, M. Gonzalez, and J. San Miguel
Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstrom's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
Haematologica,
May 1, 2007;
92(5):
635 - 642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Stamatopoulos, C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, et al.
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations
Blood,
January 1, 2007;
109(1):
259 - 270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Arcaini, M. Lazzarino, N. Colombo, S. Burcheri, E. Boveri, M. Paulli, E. Morra, M. Gambacorta, S. Cortelazzo, A. Tucci, et al.
Splenic marginal zone lymphoma: a prognostic model for clinical use
Blood,
June 15, 2006;
107(12):
4643 - 4649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Ruiz-Ballesteros, M. Mollejo, A. Rodriguez, F. I. Camacho, P. Algara, N. Martinez, M. Pollan, A. Sanchez-Aguilera, J. Menarguez, E. Campo, et al.
Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis
Blood,
September 1, 2005;
106(5):
1831 - 1838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Troen, V. Nygaard, T.-K. Jenssen, I. M. Ikonomou, A. Tierens, E. Matutes, A. Gruszka-Westwood, D. Catovsky, O. Myklebost, G. Lauritzsen, et al.
Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma
J. Mol. Diagn.,
November 1, 2004;
6(4):
297 - 307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rodriguez, N. Martinez, F. I. Camacho, E. Ruiz-Ballesteros, P. Algara, J.-F. Garcia, J. Menarguez, T. Alvaro, M. F. Fresno, F. Solano, et al.
Variability in the Degree of Expression of Phosphorylated I{kappa}B{alpha} in Chronic Lymphocytic Leukemia Cases With Nodal Involvement
Clin. Cancer Res.,
October 15, 2004;
10(20):
6796 - 6806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Cancro and J. F. Kearney
B Cell Positive Selection: Road Map to the Primary Repertoire?
J. Immunol.,
July 1, 2004;
173(1):
15 - 19.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Pileri, P. L. Zinzani, P. Went, A. Pileri Jr, and M. Bendandi
Indolent lymphoma: the pathologist's viewpoint
Ann. Onc.,
January 1, 2004;
15(1):
12 - 18.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Martinez, F. I. Camacho, P. Algara, A. Rodriguez, A. Dopazo, E. Ruiz-Ballesteros, P. Martin, J. A. Martinez-Climent, J. Garcia-Conde, J. Menarguez, et al.
The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival
Cancer Res.,
December 1, 2003;
63(23):
8226 - 8232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Orchard, R. Garand, Z. Davis, G. Babbage, S. Sahota, E. Matutes, D. Catovsky, P. W. Thomas, H. Avet-Loiseau, and D. Oscier
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
Blood,
June 15, 2003;
101(12):
4975 - 4981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. I. Camacho, P. Algara, A. Rodriguez, E. Ruiz-Ballesteros, M. Mollejo, N. Martinez, J. A. Martinez-Climent, M. Gonzalez, M. Mateo, A. Caleo, et al.
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
Blood,
May 15, 2003;
101(10):
4042 - 4046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Franco, A. M. Florena, and E. Iannitto
Splenic marginal zone lymphoma
Blood,
April 1, 2003;
101(7):
2464 - 2472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tierens, J. Delabie, A. Malecka, J. Wang, A. Gruszka-Westwood, D. Catovsky, and E. Matutes
Splenic Marginal Zone Lymphoma with Villous Lymphocytes Shows On-Going Immunoglobulin Gene Mutations
Am. J. Pathol.,
February 1, 2003;
162(2):
681 - 689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I. Chacon, M. Mollejo, E. Munoz, P. Algara, M. Mateo, L. Lopez, J. Andrade, I. G. Carbonero, B. Martinez, M. A. Piris, et al.
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients
Blood,
August 13, 2002;
100(5):
1648 - 1654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Bahler, J. A. Pindzola, and S. H. Swerdlow
Splenic Marginal Zone Lymphomas Appear to Originate from Different B Cell Types
Am. J. Pathol.,
July 1, 2002;
161(1):
81 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
